Background/Aims: Topical corticosteroid concerns (TCC) are an important issue in patients with atopic dermatitis, leading to non-adherence with poor disease control and increased health care costs. However, neither the prevalence of TCC in a more comprehensible dermatological population nor the impact of patient information on topical corticosteroids given by clinicians is known. Therefore, we assessed the prevalence, characteristics, and sources of TCC in a dermatological population and the impact of written and oral patient information on TCC. Methods: A total of 643 outpatients with various skin diseases answered a 12-item questionnaire while waiting for the doctor's visit. Patients with TCC quantified their concerns on a discrete visual analogue scale before and after patient information, which consisted of written and oral information about topical corticosteroids (TCS) given by dermatologists. Results: The prevalence of TCC was 41.5%, and that of TCC-related non-adherence was 28.3%. TCC was positively associated with age <60 years, female gender, use of complementary and alternative medicine (CAM) and non-physician health care profession. The leading concerns were skin atrophy, systemic effects, and impairment of the immune system. The most frequent sources of TCC were negative reports by media, family, or friends. Both written and oral patient information significantly reduced TCC. The number needed to benefit from patient information was approximately 2. Non-responders were more often female, TCS-inexperienced, and users of CAM with an intermediate level of education. Conclusions: TCC are highly prevalent in dermatological patients. Patient information may lower TCC in almost every second patient.

Keywords:
Patient information, Non-adherence, Topical corticosteroids, Atopic dermatitis
1.
Smith SD, Hong E, Fearns S, Blaszczynski A, Fischer G: Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol 2010;51:168-174.
2.
Aubert H, Barbarot S: Non-adherence and topical steroids (in French). Ann Dermatol Venereol 2012;139(suppl 1):S7-S12.
3.
Gustavsen HE, Gjersvik P: Topical corticosteroid phobia among parents of children with atopic dermatitis in a semirural area of Norway. J Eur Acad Dermatol Venereol 2016;30:168.
4.
Kojima R, Fujiwara T, Matsuda A, Narita M, Matsubara O, Nonoyama S, Ohya Y, Saito H, Matsumoto K: Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol 2013;30:29-35.
5.
Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C, Misery L, Young P, Chastaing M, Danou N, Lombrail P, Boralevi F, Lacour JP, Mazereeuw-Hautier J, Stalder JF, Barbarot S: Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol 2011;165:808-814.
6.
Hon KL, Kam WY, Leung TF, Lam MC, Wong KY, Lee KC, Luk NM, Fok TF, Ng PC: Steroid fears in children with eczema. Acta Paediatr 2006;95:1451-1455.
7.
Hon KL, Leung TF, Yau HC, Chan T: Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines. World J Pediatr 2012;8:263-267.
8.
Charman C, Williams H: The use of corticosteroids and corticosteroid phobia in atopic dermatitis. Clin Dermatol 2003;21:193-200.
9.
Charman CR, Morris AD, Williams HC: Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 2000;142:931-936.
10.
Moret L, Anthoine E, Aubert-Wastiaux H, Le Rhun A, Leux C, Mazereeuw-Hautier J, Stalder JF, Barbarot S: TOPICOP©: a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One 2013;8:e76493.
11.
Jenerowicz D, Czarnecka-Operacz M, Silny W: Corticosteroid phobia in patients with atopic dermatitis (in Polish). Wiad Lek 2005;58:607-615.
12.
Morren MA, Bruwiere I, Lemmens M, Goossens A, Garmyn M: Lack of compliance to topical corticosteroid therapy: possible cause and solutions (in French). J Pharm Belg 2013:20-27.
13.
Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R, Akasawa A: Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 2001;117:852-857.
14.
Fischer G: Compliance problems in paediatric atopic eczema. Australas J Dermatol 1996;37(suppl 1):S10-S13.
15.
Brown KK, Rehmus WE, Kimball AB: Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 2006;55:607-613.
16.
Mooney E, Rademaker M, Dailey R, Daniel BS, Drummond C, Fischer G, Foster R, Grills C, Halbert A, Hill S, King E, Leins E, Morgan V, Phillips RJ, Relic J, Rodrigues M, Scardamaglia L, Smith S, Su J, Wargon O, Orchard D: Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australas J Dermatol 2015;56:241-251.
17.
Bewley A; Dermatology Working Group: Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 2008;158:917-920.
18.
Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC; International Psoriasis Council: Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008;59:1009-1016.
19.
Smith SD, Stephens AM, Werren JC, Fischer GO: Treatment failure in atopic dermatitis as a result of parental health belief. Med J Aust 2013;199:467-469.
20.
Johnston GA, Bilbao RM, Graham-Brown RA: The use of complementary medicine in children with atopic dermatitis in secondary care in Leicester. Br J Dermatol 2003;149:566-571.
21.
Hong E, Smith S, Fischer G: Evaluation of the atrophogenic potential of topical corticosteroids in pediatric dermatology patients. Pediatr Dermatol 2011;28:393-396.
22.
Zschocke I, Mrowietz U, Karakasili E, Reich K: Non-adherence and measures to improve adherence in the topical treatment of psoriasis. J Eur Acad Dermatol Venereol 2014;28(suppl 2):4-9.
23.
R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2011.
24.
National Center for Complementary and Integrative Health: The Use of Complementary and Alternative Medicine in the United States. Bethesda, NIH, 2004.
25.
Kessler RC, Davis RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, Kaptchuk TJ, Eisenberg DM: Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-268.
26.
Barbosa NS, Kalaaji AN: CAM use in dermatology. Is there a potential role for honey, green tea, and vitamin C? Complement Ther Clin Pract 2014;20:11-15.
27.
Landis ET, Davis SA, Feldman SR, Taylor S: Complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med 2014;20:392-398.
28.
Fuhrmann T, Smith N, Tausk F: Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol 2010;63:1000-1005.
29.
Frass M, Strassl RP, Friehs H, Müllner M, Kundi M, Kaye AD: Use and acceptance of complementary and alternative medicine among the general population and medical personnel: a systematic review. Ochsner J 2012;12:45-56.
30.
Feldman SR: Disease burden and treatment adherence in psoriasis patients. Cutis 2013;92:258-263.
31.
Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R: Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006;17:136-142.
32.
Richards HL, Fortune DG, Griffiths CE: Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol 2006;20:370-379.
33.
Serup J, Lindblad AK, Maroti M, Kjellgren KI, Niklasson E, Ring L, Ahlner J: To follow or not to follow dermatological treatment - a review of the literature. Acta Derm Venereol 2006;86:193-197.
34.
Staab D, von Rueden U, Kehrt R, Erhart M, Wenninger K, Kamtsiuris P, Wahn U: Evaluation of a parental training program for the management of childhood atopic dermatitis. Pediatr Allergy Immunol 2002;13:84-90.
35.
Devaux S, Castela A, Archier E, Gallini A, Joly P, Misery L, Aractingi S, Aubin F, Bachelez H, Cribier B, Jullien D, Le Maitre M, Richard MA, Ortonne JP, Paul C: Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol 2012;26(suppl 3):61-67.
36.
Sterry W: Therapy with topical corticosteroids. Arch Dermatol Res 1992;284(suppl 1):S27-S29.
37.
Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG: Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582-589.
38.
Zirwas MJ, Holder JL: Patient education strategies in dermatology. Part 2. Methods. J Clin Aesthet Dermatol 2009;2:28-34.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.